Challenge with hepatitis B vaccine in children previously vaccinated with a hepatitis B-containing combination vaccine

[1]  Thomas W. Hennessy,et al.  Antibody levels and protection after hepatitis B vaccine: results of a 22-year follow-up study and response to a booster dose. , 2009, The Journal of infectious diseases.

[2]  D. Grunert,et al.  Immune memory to hepatitis B virus in 4-to-9-year old children vaccinated in infancy with four doses of hexavalent DTPa-HBV-IPV/Hib vaccine , 2009, Human vaccines.

[3]  A. Abdo,et al.  Long-term protection of hepatitis B vaccine 18 years after vaccination. , 2008, The Journal of infection.

[4]  Ryan T Novak,et al.  Persistence of Protection Against Hepatitis B Virus Infection Among Adolescents Vaccinated With Recombinant Hepatitis B Vaccine Beginning at Birth: A 15-Year Follow-Up Study , 2008, The Pediatric infectious disease journal.

[5]  M. Rapicetta,et al.  A cohort study to evaluate persistence of hepatitis B immunogenicity after administration of hexavalent vaccines , 2008, BMC infectious diseases.

[6]  H. Whittle,et al.  Long-Term Protection against HBV Chronic Carriage of Gambian Adolescents Vaccinated in Infancy and Immune Response in HBV Booster Trial in Adolescence , 2007, PloS one.

[7]  F. Meurice,et al.  Persistence of Antibodies in Children Primed with Two Different Hexavalent Diphtheria, Tetanus, Acellular Pertussis, Hepatitis B, Inactivated Poliovirus and Haemophilus influenzae Type b Vaccines and Evaluation of Booster Vaccination , 2006, Human vaccines.

[8]  A. Zanetti,et al.  Long-term immunogenicity of hepatitis B vaccination and policy for booster: an Italian multicentre study , 2005, The Lancet.

[9]  B. McMahon,et al.  Long-term efficacy of hepatitis B vaccine, booster policy, and impact of hepatitis B virus mutants. , 2005, Vaccine.

[10]  D. Kelly,et al.  Long-term persistence of immunity to hepatitis B after vaccination during infancy in a country where endemicity is low. , 2004, The Journal of infectious diseases.

[11]  M. Béné,et al.  Most humoral non-responders to hepatitis B vaccines develop HBV-specific cellular immune responses. , 2004, Vaccine.

[12]  A. Basuni,et al.  Prevalence of HBsAg mutants and impact of hepatitis B infant immunisation in four Pacific Island countries. , 2004, Vaccine.

[13]  B. McMahon,et al.  Duration of Hepatitis B Immunity in Low Risk Children Receiving Hepatitis B Vaccinations From Birth , 2004, The Pediatric infectious disease journal.

[14]  H. Margolis,et al.  Long term antibody response to hepatitis B vaccination beginning at birth and to subsequent booster vaccination , 2003, The Pediatric infectious disease journal.

[15]  J. Banatvala,et al.  Hepatitis B vaccine – do we need boosters? , 2003, Journal of viral hepatitis.

[16]  D. West,et al.  Persistence of antibody and immunologic memory in children immunized with hepatitis B vaccine at birth. , 2002, The Pediatric infectious disease journal.

[17]  S. Plotkin.  Immunologic correlates of protection induced by vaccination , 2001, The Pediatric infectious disease journal.

[18]  V. Arankalle,et al.  Ten-year serological follow up of hepatitis B vaccine recipients. , 2000, Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology.

[19]  Jing-chen Ma,et al.  A 12-year cohort study on the efficacy of plasma-derived hepatitis B vaccine in rural newborns. , 2000, World journal of gastroenterology.

[20]  European Consensus Group on Hepatitis B Immunity.  Are booster immunisations needed for lifelong hepatitis B immunity? , 2000, The Lancet.

[21]  B. McMahon,et al.  Increases in levels of antibody to hepatitis B surface antigen in an immunized population. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[22]  B. McMahon,et al.  Protection provided by hepatitis B vaccine in a Yupik Eskimo population--results of a 10-year study. , 1997, The Journal of infectious diseases.

[23]  G. Calandra,et al.  Vaccine induced immunologic memory for hepatitis B surface antigen: implications for policy on booster vaccination. , 1996, Vaccine.

[24]  M. Chang,et al.  Long-term efficacy of recombinant hepatitis B vaccine and risk of natural infection in infants born to mothers with hepatitis B e antigen. , 1995, The Journal of pediatrics.

[25]  D. West,et al.  Persistence of immunologic memory for twelve years in children given hepatitis B vaccine in infancy. , 1994, The Pediatric infectious disease journal.

[26]  R. Smego,et al.  A 9-year follow-up study of the immunogenicity and long-term efficacy of plasma-derived hepatitis B vaccine in high-risk Chinese neonates. , 1993, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[27]  S. Hadler,et al.  The prevention of hepatitis B with vaccine. Report of the centers for disease control multi-center efficacy trial among homosexual men. , 1982, Annals of internal medicine.

[28]  N. Khardori.  Humoral and Cellular Immune Responses to a Hepatitis B Vaccine Booster 15–18 Years after Neonatal Immunization , 2008 .

[29]  D. Shouval.  Hepatitis B vaccines. , 2003, Journal of hepatology.

[30]  W. Szmuness,et al.  Viral hepatitis : 1981 international symposium , 1982 .